The Immune Hot Subtype of Squamous Cell Carcinoma of Head and Neck Characterized by the High Expression of the Four Chemokines was Sensitive to Anti-Cancer Drug Targeting ERK1-MARK and RAS Pathway. The gene discussed is MARK1; the disease is cancer.